← Back to Search

Other

Oscillating Positive Expiratory Pressure Device for Rib Fractures

N/A
Recruiting
Led By Julie Dunn, MD
Research Sponsored by Poudre Valley Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 times daily, until fvc is >1.5 liters x 4 consecutive tests, or up to 4 weeks
Awards & highlights

Study Summary

This trial compares OPEP therapy to IS in patients admitted for rib fractures.

Eligible Conditions
  • Rib Fractures
  • Respiratory Complications

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 times daily, until fvc is >1.5 liters x 4 consecutive tests, or up to 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 times daily, until fvc is >1.5 liters x 4 consecutive tests, or up to 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time (hours) to stable forced vital capacity

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Oscillating Positive Expiratory Pressure DeviceExperimental Treatment1 Intervention
Each patient will be instructed on how to use the respiratory therapy device, either IS or OPEP, by research personnel and respiratory therapists. Participants will be instructed to record their compliance with the RT protocol in their respective patient diaries. Patient diaries will be collected upon discharge for analysis.
Group II: Incentive spirometryActive Control1 Intervention
Each patient will be instructed on how to use the respiratory therapy device, either IS or OPEP, by research personnel and respiratory therapists. Participants will be instructed to record their compliance with the RT protocol in their respective patient diaries. Patient diaries will be collected upon discharge for analysis.

Find a Location

Who is running the clinical trial?

Monaghan Medical CorporationUNKNOWN
1 Previous Clinical Trials
150 Total Patients Enrolled
Poudre Valley Health SystemLead Sponsor
16 Previous Clinical Trials
733 Total Patients Enrolled
Julie Dunn, MDPrincipal Investigator - Trauma Research Medical Director
Poudre Valley Health System

Media Library

Rib Fractures Clinical Trial 2023: Oscillating Positive Expiratory Pressure Device Highlights & Side Effects. Trial Name: NCT04100512 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~9 spots leftby Apr 2025